Antioxidant treatment and outcome of cortinarius orellanus poisoning: a case series

Figures & data

Table 1. Patients characteristics, renal function prior to, during and after C. orellanus poisoning, and treatment.

Patients	Comorbidity	eGFR at base-line (mL/min/1.73 m^2)	Cortinarius amount ingested	NAC and corticosteroid treatment	S-creatinine at admission (mg/dL)	S-creatinine maximum (mg/dL)	RRT for AKI	S-creatinine at discharge (mg/dL)	eGFR at 3 months (mL/min/1.73 m^2)	eGFR at 12 months (mL/min/1.73 m^2)
1	Hypertension	82	Large	Yes	16.6	18.1	Yes	N.a., chronic RRT
2		73	Large	Yes	13.6	14.1	Yes	4.8	19	22
3	Hypertensiondiabetes	71	Medium	Yes	3.8	4.2	No	1.7	43	46
4	Hypertension	68	Moderate	Yes	2.4	2.4	No	1.5	48	37
5		79	Moderate	Yes	2.9	2.9	No	2.0	49	55
6	Diabetes	70	Large	Yes	15.8	15.8	Yes	N.a., chronic RRT
7		116	Moderate	No	2.3	3.0	No	2.1	67	82
8		64	Large	No	5.4	10.1	Yes	N.a., chronic RRT
Total		78 ± 15			4.6 (2.8; 14.2)	7.1 (3.0; 14.5)		2.4 ± 1.4	45 ± 15	48 ± 20

Note: eGFR, estimated glomerular filtration rate. N.a.; not applicable. NAC, N-acetylcysteine.